Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Glimepiride [93479-97-1]
Cat# T0127-500mg
Size : 500mg
Brand : TargetMol
Glimepiride
Catalog No. T0127 CAS 93479-97-1
Synonyms: Glimperide, HOE-490
Glimepiride (HOE-490) is a long-acting, third-generation sulfonylurea with hypoglycemic activity.
All TargetMol products are for research or drug registration purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose in violation of laws and regulations.
Glimepiride, CAS 93479-97-1
Description | Glimepiride (HOE-490) is a long-acting, third-generation sulfonylurea with hypoglycemic activity. |
Targets&IC50 | SUR1:3 nM, SUR2A:5.4 nM, SUR2B:7.3 nM |
In vitro | Within diabetic rats, Glimepiride has been shown to decrease the incidence of sperm abnormalities, enhance sperm count, and bolster antioxidant capacity. |
In vivo | In both normal and insulin-resistant adipocytes, as well as in myocytes, Glimepiride effectively stimulates glucose transport, and the synthesis of lipids and glycogen. In cardiomyocytes, Glimepiride (IC50=6.8 nM) inhibits the pinacidil-activated whole-cell K(ATP) current. Additionally, in HEK 293 cells, Glimepiride (IC50=6.2 nM) blocks the K(ATP) channels formed by the co-expression of Kir6.2/SUR2A subunits. |
Synonyms | Glimperide, HOE-490 |
Molecular Weight | 490.62 |
Formula | C24H34N4O5S |
CAS No. | 93479-97-1 |
Storage
Solubility Information
DMSO: 16.67 mg/mL (33.97 mM)
References and Literature
1. Song DK, et al. Br J Pharmacol, 2001, 133(1), 193-199. 2. Müller G, et al. Horm Metab Res, 1996, 28(9), 469-487 3. Lawrence CL, et al. Br J Pharmacol, 2002, 136(5), 746-752. 4. Rabbani SI, et al. Indian J Exp Biol, 2009, 47(10), 804-810.